The independent source for health policy research, polling, and news.
7,341-7,360 of 112,980 results
NBC News reports that an average Spanish-speaking caller had to wait nearly four times longer than an English-language caller to speak to a representative. The inefficiencies are keeping many people out of Medicaid, a report says. AP says nearly one in three states have been warned by federal Medicaid officials that their call center wait times are too long.
The Hill covers a KFF analysis that found the price hikes for drugs like Ozempic and Wegovy in the U.S. are sizable compared to other wealthy nations — the list price is 10 times less in some places. Among other news items: a look at Big Pharma's high-price playbook, and news on HIV and its treatment.
The insurance giant says the mix of vendors will include Amazon and Mark Cuban's pharmacy company. CVS will still fill and manage prescriptions for Blue Shield members who need “specialty” drugs, the insurer said.
The medical board decided Thursday to state that Colorado doctors who prescribe the so-called abortion-reversal pill are operating outside of "generally accepted" practice, a move short of the ban Democrats sought, the Colorado Sun says. Other news concerns the military's abortion policy, abortion pills, and more.
The study noted that binge drinking had spiked to the "highest prevalence ... ever recorded" for those ages 35-50. Separately, a survey found that the share of Americans older than 65 who have used marijuana leaped from 11% in 2009 to 32% in 2019.
The CDC has confirmed that people without health insurance won't immediately be able to get free covid shots at pharmacies like CVS or Walgreens when the next-generation vaccines are unveiled in a few weeks. Meanwhile, both Moderna and Pfizer reported that their new shots are effective against the "Eris" subvariant currently circulating in the U.S.
Today's early morning highlights from the major news organizations.
This week's selections of health policy studies and briefs are from the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota.
The U.S. Court of Appeals for the 10th Circuit invalidated four provisions of an Oklahoma law targeting PBMs. In Ohio, a marijuana legalization question will be on the fall ballot. In the Bay Area, some 150,000 residents will have their Medi-Cal eligibility reconsidered. And more.
Over 73,000 ventilators were recalled in March, but new FDA data show the issue is associated with at least one death and two injuries. Among other news: the FDA approved the first treatment for a rare bone disease; the American Red Cross tussles with the Justice Dept. over antitrust; and more.
Summer covid cases are rising, Axios reminds us, but a poll shows that the public isn't keen to start wearing masks again or even to test for covid. In other news, the CDC says a relatively new strain of E. coli is behind multiple outbreaks over recent years, including those linked to leafy greens.
The New York surgery involved a patient who was brain dead and replaced both kidneys with one from a pig. The goal is to win approval for wider clinical trials. Meanwhile, the national system for allocating and distributing human organs for transplant is set for an overhaul.
Editorial writers discuss these public health issues.
Stat reports that health care industry executives pocketed, collectively, $4 billion in an otherwise tricky year, economically speaking. Meanwhile, residents in a southern Colorado city are reportedly arguing their nonprofit local hospitals aren't providing enough charity care to justify their status.
A new study found that gastrointestinal, endocrine, and breast cancers were climbing at the fastest rates. Meanwhile, NBC News reports that price gouging by gray market vendors of chemo drugs amid current supply shortages is hitting some hospitals hard.
Researchers found that using piroxicam, a common arthritis anti-inflammatory drug, with Levonorgestrel, or Plan B, significantly increased the typical effectiveness window of 24 hours. In other news, Facebook's parent company is criticized for rating reproductive health for adults-only.
A federal appeals court decided Wednesday that the drug, which is used in medication abortions, shouldn't be prescribed by telemedicine or past seven weeks of pregnancy. But the drug will remain available until a ruling from the Supreme Court.
Today's early morning highlights from the major news organizations.
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
The legislation in question banned gender care for minors and limited trans youngsters' participation in sports through college. The GOP supermajority in the state is now seeking to overturn the veto, AP reports. Separately, experts push back against Texas lawmakers who say puberty blockers are "experimental."
© 2026 KFF